Author: EMJ
Citation: EMJ Dermatol. 2026.https://doi.org/10.33590/emjdermatol/IEYW6199
Original publication¹
LEO Pharma requested removal of this sponsored material due to internal compliance updates.
Reference:
1. Humphry N. Tralokinumab in Moderate-to-Severe Atopic Dermatitis: The Latest Data. EMJ Dermatol. 2025;13[Suppl 2]:2-10. https://doi.org/10.33590/emjdermatol/PRLP5831
